XM does not provide services to residents of the United States of America.
S
S

Solvay

News

KBC adds Azelis to top pick list on Q4 hopes, removes Solvay

BUZZ-KBC adds Azelis to top pick list on Q4 hopes, removes Solvay ** KBC replaces Solvay SOLB.BR with Azelis AZE.BR in its Dynamic Top Pick list, expecting the latter to report organic growth in all regions in Q4 for the first time since Q3 2022 ** Shares in Azelis rise 7.5 %, on track for their best day since April if gains hold, while Solvay fall
S

Compass Group, Pandora, SSP Group

EUROPE RESEARCH ROUNDUP-Compass Group, Pandora, SSP Group Nov 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Compass Group, Pandora and SSP Group, on Thursday. HIGHLIGHTS * Compass Group CPG.L : Jefferies raises target price to 3,000p from 2,500p * Just Eat Takeaway.Com JETJ.L : JP Morgan raises target price to 1,415p from 1,396p * Marks and Spencer Group MKS.L : JP Morgan raises target price to 440p from 425p * Pandora PNDORA.C
A
B
C
C
E
F
F
G
G
I
K
M
P
P
S
S
S
S
S
Z
A

Solvay drops after cost savings-driven beat

BUZZ-Solvay drops after cost savings-driven beat ** Shares in Belgian chemicals group Solvay SOLB.BR fall around 5%, with analysts pointing to low-quality earnings beat and profit taking as a likely reason for the drop ** "The market is arguably less excited about the outperformance of EBITDA vs expectations than would normally be the case given th
S

Solvay says cost savings will limit 2024 profit decline closer to 10%

UPDATE 3-Solvay says cost savings will limit 2024 profit decline closer to 10% Adds CEO quotes in paragraphs 4, 8-9 By Dimitri Rhodes Nov 6 (Reuters) - Belgian chemicals group Solvay SOLB.BR said on Wednesday it expected its 2024 core profit decline to be closer to 10%, at the positive end of its earlier guidance range, as its cost cutting measures yield results faster than anticipated.
S

Solvay sees 2024 profit decline at shallow end of its outlook range

CORRECTED-UPDATE 2-Solvay sees 2024 profit decline at shallow end of its outlook range Corrects headline and paragraph 1 to say the profit decline is expected at shallow end of guidance range, not the steeper one By Dimitri Rhodes Nov 6 (Reuters) - Belgian chemicals group Solvay SOLB.BR said on Wednesday it expected its 2024 core profit decline to be closer to 10%, at the positive end of its guidance range, even as negative pricing trends and soft demand were set to persist into the final quarte
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.